These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 11726500)
21. Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma. Yao J; Pollock RE; Lang A; Tan M; Pisters PW; Goodrich D; El-Naggar A; Yu D Clin Cancer Res; 1998 Apr; 4(4):1065-70. PubMed ID: 9563903 [TBL] [Abstract][Full Text] [Related]
22. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Kovar H; Jug G; Aryee DN; Zoubek A; Ambros P; Gruber B; Windhager R; Gadner H Oncogene; 1997 Oct; 15(18):2225-32. PubMed ID: 9393981 [TBL] [Abstract][Full Text] [Related]
23. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases. Greider C; Chattopadhyay A; Parkhurst C; Yang E Oncogene; 2002 Nov; 21(51):7765-75. PubMed ID: 12420213 [TBL] [Abstract][Full Text] [Related]
24. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes. Marzo N; Mora C; Fabregat ME; Martín J; Usac EF; Franco C; Barbacid M; Gomis R Diabetologia; 2004 Apr; 47(4):686-94. PubMed ID: 15298346 [TBL] [Abstract][Full Text] [Related]
26. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma. Gao L; Liu L; van Meyel D; Cairncross G; Forsyth P; Kimmel D; Jenkins RB; Lassam NJ; Hogg D Clin Cancer Res; 1997 Jun; 3(6):977-81. PubMed ID: 9815774 [TBL] [Abstract][Full Text] [Related]
27. Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: a clinic-based population study. Platz A; Hansson J; Ringborg U Int J Cancer; 1998 Sep; 78(1):13-5. PubMed ID: 9724087 [TBL] [Abstract][Full Text] [Related]
28. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes. Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280 [TBL] [Abstract][Full Text] [Related]
29. Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule. Fåhraeus R; Laín S; Ball KL; Lane DP Oncogene; 1998 Feb; 16(5):587-96. PubMed ID: 9482104 [TBL] [Abstract][Full Text] [Related]
30. Mutational analysis of N-ras, p53, p16INK4a, p14ARF and CDK4 genes in primary human malignant mesotheliomas. Papp T; Schipper H; Pemsel H; Bastrop R; Muller KM; Wiethege T; Weiss DG; Dopp E; Schiffmann D; Rahman Q Int J Oncol; 2001 Feb; 18(2):425-33. PubMed ID: 11172613 [TBL] [Abstract][Full Text] [Related]
31. Sequential extension of proliferative lifespan in human fibroblasts induced by over-expression of CDK4 or 6 and loss of p53 function. Morris M; Hepburn P; Wynford-Thomas D Oncogene; 2002 Jun; 21(27):4277-88. PubMed ID: 12082615 [TBL] [Abstract][Full Text] [Related]
32. Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth. Williams RT; Barnhill LM; Kuo HH; Lin WD; Batova A; Yu AL; Diccianni MB PLoS One; 2014; 9(2):e88219. PubMed ID: 24505435 [TBL] [Abstract][Full Text] [Related]
34. Absence of R24C mutation of the CDK4 gene in leukemias and solid tumors. Mori N; Yang R; Kawamata N; Miller CW; Mizoguchi H; Koeffler HP Int J Hematol; 2003 Apr; 77(3):259-62. PubMed ID: 12731669 [TBL] [Abstract][Full Text] [Related]
35. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course. Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362 [TBL] [Abstract][Full Text] [Related]
36. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors. Arcellana-Panlilio MY; Egeler RM; Ujack E; Magliocco A; Stuart GC; Robbins SM; Coppes MJ Genes Chromosomes Cancer; 2002 Oct; 35(2):176-81. PubMed ID: 12203782 [TBL] [Abstract][Full Text] [Related]
37. CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus. Hernández L; Beà S; Pinyol M; Ott G; Katzenberger T; Rosenwald A; Bosch F; López-Guillermo A; Delabie J; Colomer D; Montserrat E; Campo E Cancer Res; 2005 Mar; 65(6):2199-206. PubMed ID: 15781632 [TBL] [Abstract][Full Text] [Related]
38. Lack of cyclin-dependent kinase 4 inhibits c-myc tumorigenic activities in epithelial tissues. Miliani de Marval PL; Macias E; Rounbehler R; Sicinski P; Kiyokawa H; Johnson DG; Conti CJ; Rodriguez-Puebla ML Mol Cell Biol; 2004 Sep; 24(17):7538-47. PubMed ID: 15314163 [TBL] [Abstract][Full Text] [Related]
39. Genes involved in melanoma: an overview of INK4a and other loci. Castellano M; Parmiani G Melanoma Res; 1999 Oct; 9(5):421-32. PubMed ID: 10596908 [TBL] [Abstract][Full Text] [Related]
40. Driving the cell cycle to cancer. Malumbres M; Hunt SL; Sotillo R; Martín J; Odajima J; Martín A; Dubus P; Ortega S; Barbacid M Adv Exp Med Biol; 2003; 532():1-11. PubMed ID: 12908544 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]